{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:28:37Z","timestamp":1794652117648,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T00:00:00Z","timestamp":1498694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11912-017-0615-4","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T05:18:38Z","timestamp":1498713518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current Management Strategy for Penile Cancer and Future Directions"],"prefix":"10.1007","volume":"19","author":[{"given":"Tanya B.","family":"Dorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie K.","family":"Ballas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Schuckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"615_CR1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","volume":"49","author":"RHA Verhoeven","year":"2013","unstructured":"Verhoeven RHA, Janssen-Heijnen MLG, Saum KU, Zanetti R, Caldarella A, et al. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer. 2013;49:1414\u201321.","journal-title":"Eur J Cancer"},{"key":"615_CR2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ijc.21009","volume":"116","author":"JR Daling","year":"2005","unstructured":"Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ an dinvasive disease. Int J Cancer. 2005;116:606.","journal-title":"Int J Cancer"},{"key":"615_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","volume":"20","author":"DM Backes","year":"2009","unstructured":"Backes DM, KUrman RJ, Pimenta JM, et al. Systemiatic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20:449.","journal-title":"Cancer Causes Control"},{"key":"615_CR4","doi-asserted-by":"crossref","unstructured":"Jakobsen JK, Krarup KP, Sommer P, Nerstrom H, Sorensen JA, Bakholdt V, et al. Survival impact of early lymph node staging in a national study on 454 Danish men with penile cancer. Eur Urol Suppl. 2015;","DOI":"10.1016\/S1569-9056(15)60699-6"},{"key":"615_CR5","doi-asserted-by":"crossref","first-page":"53e1","DOI":"10.1016\/j.urolonc.2013.08.010","volume":"32","author":"A Flaherty","year":"2014","unstructured":"Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, et al. Implications for human papillomavirus in penile cancer. Urol Oncol. 2014;32:53e1\u20138.","journal-title":"Urol Oncol"},{"key":"615_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.juro.2014.08.087","volume":"193","author":"RS Djajadiningrat","year":"2015","unstructured":"Djajadiningrat RS, Jordanova ES, Kroon BK, vanWerkhoven E, deJong J, Pronk DTM, et al. Human papillomavirus prevalence in invasive penile cancer and association with clinical outcomes. J Urol. 2015;193:526\u201331.","journal-title":"J Urol"},{"key":"615_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/14728222.2013.783571","volume":"17","author":"G diLorenzo","year":"2013","unstructured":"diLorenzo G, Buonerba C, Gaudioso G, Quarto VG, DeDomenico R, et al. EGFR mutational status in penile cancer. Expert Opin Ther Target. 2013;17:501\u20135.","journal-title":"Expert Opin Ther Target"},{"key":"615_CR8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clgc.2016.01.013","volume":"14","author":"TB Dorff","year":"2016","unstructured":"Dorff TB, Schuckman AK, Schwartz R, Rashad S, Bulbul A, et al. Epidermal growth factor receptor, excision-repair cross-complementation group 1 protein, and thymidylate synthase expression in penile cancer. Clin Genitourinary Cancer. 2016;14:450\u20136.","journal-title":"Clin Genitourinary Cancer"},{"key":"615_CR9","doi-asserted-by":"crossref","unstructured":"Gou H-F, Li X, Qiu M, Cheng K, Li L-H, Dong H, et al. Epidermal growth factor receptor (EGFR)-RAS pathway in penile squamous cell carcinoma. PLOS one 2013; e62175.","DOI":"10.1371\/journal.pone.0062175"},{"key":"615_CR10","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Ottenhof SR, Djajadiningrat RS, de Jong J, Thygesen HH, HOrenblas S, Jordanova ES. Expression of programmed death ligand 1 (PD-L1) in penile cancer is of prognostic value and associated with HPV status. J Urol. 2016; doi:\n10.1016\/j.juro.2016.09.088\n\n. HPV negative tumors are more likely to stain for PD-L1 and PD-L1+ tumors have a better prognosis. This may translate into therapeutic implications after prospective validation.","DOI":"10.1016\/j.juro.2016.09.088"},{"key":"615_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","volume":"21","author":"SM Ali","year":"2016","unstructured":"\u2022\u2022 Ali SM, Pal SK, Wang K, Palma NA, Sanford E, Bailey M, et al. Comprehensive genomic profiling of advanced penile carcinoma suggests a high frequency of clinically relevant genomic alterations. Oncologist. 2016;21:33\u20139. Although only 20 patients were sequenced, there were potentially \u201cdruggable\u201d alterations identified outside of EGFR: BRCA, CDKN2a, NOTCH, etc.","journal-title":"Oncologist"},{"key":"615_CR12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.urology.2014.11.048","volume":"85","author":"R Veeteratterapillay","year":"2015","unstructured":"Veeteratterapillay R, Teo L, Asterling S, Greene D. Oncologic outcomes of penile cancer treatment at a UK supraregional center. Urol. 2015;85:1097\u2013103.","journal-title":"Urol"},{"key":"615_CR13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","volume":"11","author":"PE Clark","year":"2013","unstructured":"Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, et al. Penile Cancer. J Natl Compr Cancer Netw. 2013;11:594\u2013615.","journal-title":"J Natl Compr Cancer Netw"},{"key":"615_CR14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","volume":"192","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat RS, van Werkhoven E, Meinhardt W, van Rhijm BWG, Bex A, et al. Penile sparing surgery for penile cancer\u2014does it affect survival? J Urol. 2014;192:120\u20136.","journal-title":"J Urol"},{"key":"615_CR15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.juro.2014.04.014","volume":"192","author":"JM Kieffer","year":"2014","unstructured":"Kieffer JM, Djajadiningrat RS, vanMuilekom EAM, Graafland NM, Horenblas S, Aaronson NK. Quality of life for patients treated for penile cancer. J Urol. 2014;192:1105\u201310.","journal-title":"J Urol"},{"key":"615_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrurol.2016.54","volume":"13","author":"AL Burnett","year":"2016","unstructured":"Burnett AL. Penile preserving and reconstructive surgery in the management of penile cancer. Nat rev Urol. 2016;13:249\u201357.","journal-title":"Nat rev Urol"},{"key":"615_CR17","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: penile cancer, version 2.2016. Available at: \nhttp:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/penile.pdf .\n\n Accessed November 11, 2016."},{"issue":"5","key":"615_CR18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2010.08.015","volume":"58","author":"NM Graafland","year":"2010","unstructured":"Graafland NM, Lam W, Leijte JA, et al. Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol. 2010 Nov;58(5):742\u20137.","journal-title":"Eur Urol"},{"issue":"6","key":"615_CR19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.urolonc.2009.10.014","volume":"29","author":"I Alkatout","year":"2011","unstructured":"Alkatout I, Naumann CM, Hedderich J, et al. Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination. Urol Oncol. 2011;29(6):774\u201381.","journal-title":"Urol Oncol"},{"key":"615_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.urolonc.2011.02.020","volume":"31","author":"CE Ercole","year":"2013","unstructured":"Ercole CE, Pow-Sang JM, Spiess PE. Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer. Urol Oncol: Sem Invest. 2013;31:505\u201316.","journal-title":"Urol Oncol: Sem Invest"},{"key":"615_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.urology.2016.06.033","volume":"96","author":"BR Winters","year":"2016","unstructured":"Winters BR, Mossanen MN, Hold SK, Lin DW, Wright JL. Predictors of nodal upstaging in clinical node negative patients with penile carcinoma: a national cancer database analysis. Urol. 2016;96:29\u201334.","journal-title":"Urol"},{"key":"615_CR22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.brachy.2015.03.008","volume":"14","author":"S Hasan","year":"2015","unstructured":"\u2022\u2022 Hasan S, Francis A, Hagenauer A, Hirsh A, Kaminsky D, et al. The role of brachytherapy in organ preservation for penile cancer: a meta-analysis and review of the literature. Brachytherapy. 2015;14:517\u201324. By conducting a meta-analysis with large numbers of patients, the role for brachytherapy in organ preservation becomes better defined; in early stage disease, local control rates are comparable to those achieved by partial penectomy.","journal-title":"Brachytherapy"},{"key":"615_CR23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","volume":"177","author":"AP Lont","year":"2007","unstructured":"Lont AP, Bk K, Gallee MP, van Tinteren H, Moonen LM, Horenblas S. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol. 2007;177:947\u201352.","journal-title":"J Urol"},{"key":"615_CR24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.juro.2013.10.140","volume":"191","author":"G Lughezzani","year":"2014","unstructured":"Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, et al. The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience. J Urol. 2014;191:944\u201382.","journal-title":"J Urol"},{"key":"615_CR25","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol. 2010;28:3851\u20137.","journal-title":"J Clin Oncol"},{"key":"615_CR26","first-page":"323","volume":"14","author":"N Nicolai","year":"2015","unstructured":"Nicolai N, Sangalli LM, Necchi A, Giannatempo P, Paganoni AM, Colecchia M, et al. A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings. Clin GU Cancer. 2015;14:323\u201330.","journal-title":"Clin GU Cancer"},{"key":"615_CR27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","volume":"186","author":"KN Franks","year":"2011","unstructured":"Franks KN, Kancherla K, Sethugavalar B, Whelan P, Eardley I, Kiltie AE. Radikotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol. 2011;186:524\u20139.","journal-title":"J Urol"},{"key":"615_CR28","doi-asserted-by":"publisher","unstructured":"\u2022 Necchi A, Lo Vullo S, Nicolai N, Raggi D, Giannatempo P, Coecchia M, et al. Prognostic factors of adjuvant taxane, cisplatin, and 5-fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy. Clin GU Cancer 2016; in press. DOI: \n10.1016\/j.dgc2015.07.009\n\n. This builds upon the practice-changing Pagliaro study which identified a significant improvement in outcomes for N2\/N3 patients treated with neoadjuvant chemotherapy compared to historical controls; here, adjuvant chemotherapy is found to also improve outcomes although again not a randomized study\n                        .","DOI":"10.1016\/j.dgc2015.07.009"},{"key":"615_CR29","doi-asserted-by":"crossref","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","volume":"33","author":"P Sharma","year":"2015","unstructured":"Sharma P, Djajadiningrat R, Zargar-Shoshtari K, Catanzaro M, Zhu Y, Nicolai N, et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol. 2015;33:496.e17\u201323.","journal-title":"Urol Oncol"},{"key":"615_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.urology.2013.08.074","volume":"83","author":"A Brown","year":"2014","unstructured":"Brown A, Ma Y, Danenberg K, Schuckman A, Pinski J, Pagliaro L, et al. Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases. Urology. 2014;83:159\u201365.","journal-title":"Urology"},{"key":"615_CR31","first-page":"231","volume":"14","author":"A Necchi","year":"2015","unstructured":"\u2022\u2022 Necchi A, Giannatempo P, Lo Vullo S, Raggi D, Nicolai N, Colecchia M, et al. Panitumumab treatment for advanced penile squamous cell carcinoma when surgery and chemotherapy have failed. Clin GU Cancer. 2015;14:231\u20136. Provides support for study of EGFR targeted therapy in advanced penile cancer.","journal-title":"Clin GU Cancer"},{"key":"615_CR32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","volume":"85","author":"J Wang","year":"2015","unstructured":"Wang J, Pettaway C, Pagliaro LC. Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes. Urology. 2015;85:1104\u201310.","journal-title":"Urology"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-017-0615-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-017-0615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-017-0615-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T03:18:40Z","timestamp":1501298320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-017-0615-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["615"],"URL":"https:\/\/doi.org\/10.1007\/s11912-017-0615-4","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]},"article-number":"54"}}